calcium dobesilate has been researched along with Diabetes Mellitus, Type 1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ambrósio, AF; Bauer, J; Cunha-Vaz, J; Leal, EC; Liberal, J; Santiago, AR; Voabil, P | 1 |
| Ganado, P; Ruiz, E; Sanz, M; Tejerina, T | 1 |
2 other study(ies) available for calcium dobesilate and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Calcium Dobesilate Is Protective against Inflammation and Oxidative/Nitrosative Stress in the Retina of a Type 1 Diabetic Rat Model.
Topics: Animals; Apoptosis; Blood-Retinal Barrier; Calcium Dobesilate; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Hemostatics; Inflammation; Male; Oxidative Stress; Rats; Rats, Wistar; Retina | 2017 |
In vitro effects of calcium dobesilate on the responsiveness of spontaneously diabetic rat aorta.
Topics: Acetylcholine; Animals; Aorta, Thoracic; Calcium Dobesilate; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hemostatics; In Vitro Techniques; Male; Muscle Contraction; Muscle Relaxation; NG-Nitroarginine Methyl Ester; Nitroprusside; Norepinephrine; Rats; Rats, Inbred BB; Rats, Wistar; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 1998 |